• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ERICVA 简化风险评分预测严重肢体缺血患者的截肢。

ERICVA Risk Scale simplified as a predictor of amputation in critical limb ischemia.

机构信息

School of Medicine, Antenor Orrego Private University, Trujillo 13007, Peru.

School of Medicine, Antenor Orrego Private University, Trujillo 13007, Peru; Surgery Department, Alta Complejidad Virgen de la Puerta Hospital, Essalud, Trujillo 13007, Peru.

出版信息

J Med Vasc. 2022 Jul-Aug;47(3):116-124. doi: 10.1016/j.jdmv.2022.07.002. Epub 2022 Aug 2.

DOI:10.1016/j.jdmv.2022.07.002
PMID:36055680
Abstract

OBJECTIVE

Demonstrate that simplified ERICVA (Valladolid Critical Limb Ischaemia Risk Scale) is useful in predicting amputation in chronic limb-threatening ischemia (CLI) after one year of revascularization.

METHODS

A retrospective cohort study was performed. We analyzed the medical records of 93 patients over the age of 35 with the diagnosis of CLI who were treated in the Department of Internal Medicine, Orthopedics or in the Cardiovascular Surgery Unit of the Víctor Lazarte Echegaray Hospital and the High Complexity Virgen de La Puerta Hospital during the period 2015-2018. The simplified ERICVA score was determined in patients before surgical and endovascular revascularization. We included 31 patients who scored 2 or more points in the exposed group and 62 patients who scored less than 2 points in the group not exposed to amputation risk. The collected data was analyzed with the statistical program SPSS where the Relative Risk and significance was obtained with Pearson's Chi-square. The multivariate analysis was also carried out in order to obtain the adjusted relative risk.

RESULTS

It was identified that the simplified ERICVA score greater than or equal to 2 points was more frequent in those who underwent amputation (90.3%) compared to patients who did not undergo amputation (4.8%), increasing the risk of amputation in those patients with CLI who underwent revascularization (RR: 18.67, P<0.001). It was also possible to identify that within the group of patients that showed a high risk of amputation according to the ERICVA scale, they had a higher risk of major amputation (RR: 9.32, P<0.001) as opposed to the risk of minor amputation (RR: 1, 89, P=0.193). Among the items of the simplified ERICVA scale, the preoperative neutrophil-lymphocyte ratio and hematocrit were significantly higher in the group of amputated patients (P<0.001). In addition, it was possible to identify that the score greater than or equal to 2 was independently associated with the risk of amputation in patients revascularized with CLI (RR: 13.5, P<0.001).

CONCLUSION

In our patient population, the simplified ERICVA scale is useful in predicting major and minor amputation in critical limb ischemia after revascularization. The present data showed that the patients who had a simplified ERICVA score greater than or equal to 2 had a higher risk of major amputation compared to the risk of minor amputation. However, it is important to highlight that the impact on the prediction of minor amputation is greater because in some circumstances major amputation can appear as a complication of CLI.

摘要

目的

证明简化版 ERICVA(巴利亚多利德肢体严重缺血风险评分)在预测血管重建后慢性肢体威胁性缺血(CLI)患者一年后截肢方面具有一定作用。

方法

本研究为回顾性队列研究。我们分析了 2015 年至 2018 年间在瓦拉达理德·埃切加雷医院内科、骨科或心血管外科部门就诊的 93 名年龄超过 35 岁的 CLI 诊断患者的医疗记录。在接受手术和血管内血运重建之前,确定了简化版 ERICVA 评分。我们将 31 名评分≥2 分的患者纳入暴露组,62 名评分<2 分的患者纳入未暴露于截肢风险组。使用统计程序 SPSS 分析收集的数据,使用 Pearson 卡方获得相对风险和显著性。还进行了多变量分析,以获得调整后的相对风险。

结果

在接受截肢的患者中,简化版 ERICVA 评分≥2 分更为常见(90.3%),而未接受截肢的患者为 4.8%,这增加了 CLI 患者血管重建后截肢的风险(RR:18.67,P<0.001)。还可以发现,根据 ERICVA 评分,在显示高截肢风险的患者组中,他们有更高的主要截肢风险(RR:9.32,P<0.001),而不是小截肢风险(RR:1,89,P=0.193)。在简化版 ERICVA 评分的项目中,截肢患者的术前中性粒细胞-淋巴细胞比值和红细胞压积明显更高(P<0.001)。此外,还可以发现,在 CLI 血管重建患者中,评分≥2 与截肢风险独立相关(RR:13.5,P<0.001)。

结论

在我们的患者群体中,简化版 ERICVA 评分可用于预测血管重建后 CLI 患者的大、小截肢。本研究数据显示,简化版 ERICVA 评分≥2 的患者发生大截肢的风险高于小截肢的风险。然而,值得强调的是,其对小截肢的预测影响更大,因为在某些情况下,大截肢可能是 CLI 的并发症。

相似文献

1
ERICVA Risk Scale simplified as a predictor of amputation in critical limb ischemia.ERICVA 简化风险评分预测严重肢体缺血患者的截肢。
J Med Vasc. 2022 Jul-Aug;47(3):116-124. doi: 10.1016/j.jdmv.2022.07.002. Epub 2022 Aug 2.
2
Validation of ERICVA Risk Score as a Predictor of One Year Amputation-Free Survival of Patients with Critical Limb Ischemia.验证 ERICVA 风险评分能否预测重症肢体缺血患者一年无截肢生存率。
Ann Vasc Surg. 2021 Aug;75:171-178. doi: 10.1016/j.avsg.2021.02.013. Epub 2021 Apr 2.
3
Design of a New Risk Score in Critical Limb Ischaemia: The ERICVA Model.严重肢体缺血新风险评分的设计:ERICVA模型
Eur J Vasc Endovasc Surg. 2016 Jan;51(1):90-9. doi: 10.1016/j.ejvs.2015.09.025. Epub 2015 Nov 18.
4
Outcomes of Critical Limb Ischemia in an Urban, Safety Net Hospital Population with High WIfI Amputation Scores.在一家城市安全网医院中,具有高WIFI截肢评分的严重肢体缺血患者的治疗结果。
Ann Vasc Surg. 2017 Jan;38:84-89. doi: 10.1016/j.avsg.2016.08.005. Epub 2016 Aug 19.
5
Clinical outcomes of bypass-first versus endovascular-first strategy in patients with chronic limb-threatening ischemia due to infrageniculate arterial disease.对于因膝下动脉疾病导致慢性肢体威胁性缺血的患者,采用旁路优先与血管内优先策略的临床结果。
J Vasc Surg. 2019 Jan;69(1):156-163.e1. doi: 10.1016/j.jvs.2018.05.244.
6
Temporal trends and outcomes of critical limb ischemia among patients with chronic kidney disease.慢性肾脏病患者的严重肢体缺血的时间趋势和结局。
Vasc Med. 2021 Apr;26(2):155-163. doi: 10.1177/1358863X20951270. Epub 2020 Oct 1.
7
Clinical presentation and outcome after failed infrainguinal endovascular and open revascularization in patients with chronic limb ischemia.慢性肢体缺血患者经腔内血管和开放再血管化治疗失败后的临床表现和结局。
J Vasc Surg. 2013 Jul;58(1):98-104.e1. doi: 10.1016/j.jvs.2012.12.076. Epub 2013 May 14.
8
A prognostic score for clinical success after revascularization of critical limb ischemia in hemodialysis patients.血液透析患者临界肢体缺血血运重建后临床成功的预后评分。
J Vasc Surg. 2019 Sep;70(3):901-912. doi: 10.1016/j.jvs.2018.11.034. Epub 2019 Mar 25.
9
Outcomes of open and endovascular lower extremity revascularization in active smokers with advanced peripheral arterial disease.患有晚期外周动脉疾病的活跃吸烟者进行开放性和血管腔内下肢血管重建术的结果。
J Vasc Surg. 2017 Jun;65(6):1680-1689. doi: 10.1016/j.jvs.2017.01.025.
10
Contemporary Revascularization Strategies and Outcomes Among Patients With Diabetes With Critical Limb Ischemia: Insights From the National Inpatient Sample.糖尿病合并严重肢体缺血患者的当代血运重建策略及结局:来自全国住院患者样本的见解
JACC Cardiovasc Interv. 2021 Mar 22;14(6):664-674. doi: 10.1016/j.jcin.2020.11.032. Epub 2021 Feb 24.

引用本文的文献

1
The Role of Neutrophils in Lower Limb Peripheral Artery Disease: State of the Art and Future Perspectives.中性粒细胞在下肢外周动脉疾病中的作用:现状与未来展望。
Int J Mol Sci. 2023 Jan 6;24(2):1169. doi: 10.3390/ijms24021169.